Dark | Light
# Mineralys Therapeutics, Inc. (MLYS)

MLYS stock shows mixed signals with a director's significant share purchase boosting confidence, yet social mentions and creator activity are sharply declining.

### About Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for cardiovascular and renal diseases.  
Mineralys Therapeutics, Inc. uses the ticker $MLYS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Mineralys Therapeutics, Inc. (MLYS) market dominance near a 52-week low at [-------].
- Mineralys Therapeutics, Inc. (MLYS) trading volume is up 14.78% from the previous week.
- Mineralys Therapeutics, Inc. (MLYS) social dominance is up 878.95% from the previous week.
- Mineralys Therapeutics, Inc. (MLYS) creators is up 64.05% from the previous month.
- Mineralys Therapeutics, Inc. (MLYS) engagements is up 65.76% from the previous week.
- Mineralys Therapeutics, Inc. (MLYS) mentions is up 87.4% from the previous month.
- Mineralys Therapeutics, Inc. (MLYS) posts created is up 177.78% from the previous week.

### Price: $27.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/close.tsv)  
The stock price is experiencing volatility near its 52-week high, potentially due to decreased social mentions and creator activity, suggesting a short-term correction despite positive trial results and analyst upgrades.  

24-Hour: 0.5%
7-Day: -9.74%
30-Day: -15.7%

1-Year High: $47.30 on 2025-11-12  
1-Year Low: $8.80 on 2025-02-25  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/alt_rank.tsv)  
Mineralys Therapeutics, Inc. (MLYS) is currently AltRank #1,368 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +1,289  
[--] Month: [-----] +309  
[--] Months: [-----] +901  
[--] Year: [-----] +1,029  
1-Year High: [-----] on 2025-11-06  
1-Year Low: [--] on 2025-09-21  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-03-10  
1-Year Low: [--] on 2025-04-25  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +66%  
[--] Month: [-------] +5.60%  
[--] Months: [---------] +52%  
[--] Year: [---------] +158%  
1-Year High: [-------] on 2025-09-02  
1-Year Low: [---] on 2025-08-09  

Engagements by network (24h):
Reddit: [--]
X: [-----]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +22%  
[--] Month: [---] +87%  
[--] Months: [-----] +58%  
[--] Year: [-----] +782%  
1-Year High: [---] on 2025-09-03  
1-Year Low: [--] on 2025-08-09  

Mentions by network (24h):
Reddit: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Mineralys Therapeutics, Inc. (MLYS) in the last [--] hours which is down 15% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +14%  
[--] Month: [---] +64%  
[--] Months: [---] -9%  
[--] Year: [-----] +680%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-08-18  

The most influential creators that mention Mineralys Therapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [-----]       |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [-----]       |
| [@Angelinafrazier](/creator/twitter/Angelinafrazier) | [--]    |           | [--]     | [--]          |
| [@Lisa60841638541](/creator/twitter/Lisa60841638541) | [--]    | [--]         | [--]     | [--]          |
| [@InsideDashboard](/creator/twitter/InsideDashboard) | [--]    | [-----]     | [--]     | [--]          |

[View More](/list/creators/$mlys/100)
  
  
### Sentiment: 88%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/sentiment.tsv)  
Current Value: 88%  
Daily Average: 77%  
[--] Week: 100% no change  
[--] Month: 77% +3%  
[--] Months: 77% -3%  
[--] Year: 77% +10%  
1-Year High: 100% on 2025-02-16  
1-Year Low: 15% on 2025-12-29  

Most Supportive Themes:
- Director Share Purchase: (40%) Director Srinivas Akkaraju purchased $15M in shares, signaling confidence.
  
Most Critical Themes:
- Declining Social Activity: (30%) Mentions of MLYS are down 77% and creators mentioning MLYS are down 84% over the last month.
  
  
  
### Social Dominance: 0.00327%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/social_dominance.tsv)  
Current Value: 0.00327%  
Daily Average: 0.00903%  
[--] Week: 0.037% +0.033%  
[--] Month: 0.005% +0.0012%  
[--] Months: 0.005% +0.0027%  
[--] Year: 0.005% -0.003%  
1-Year High: 0.061% on 2025-09-03  
1-Year Low: 0.0013% on 2025-08-09  
  
  
### Market Dominance: 0.00251%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/market_dominance.tsv)  
Current Value: 0.00251%  
Daily Average: 0%  
1-Year High: 0.00448% on 2025-11-12  
1-Year Low: 0.00247% on 2026-02-13  
  
  
### Market Cap: $2,215,918,768
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mlys/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mlys/time-series/market_cap.tsv)  
Current Value: $2,215,918,768  
Daily Average: $2,952,989,812  
[--] Week: $2,215,918,768 -8.40%  
[--] Month: $2,215,918,768 -11%  
1-Year High: $3,745,694,117 on 2025-11-12  
1-Year Low: $2,184,262,786 on 2026-02-13  

### Top Mineralys Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"My watch list of catalysts- update 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD $PVLA Ph3 mLM My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC"  
[X Link](https://x.com/Andre_AGTC/status/2022077136581083568) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-12T22:35Z [----] followers, [----] engagements


"My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3"  
[X Link](https://x.com/Andre_AGTC/status/2021950868871163978) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-12T14:13Z [----] followers, [----] engagements


"My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET + NDA DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $NKTR 52w AD maintenance $BLTE NDA STGD1 H1 My watch list near term catalysts $AXSM PDUFA ADA $XENE Ph3"  
[X Link](https://x.com/Andre_AGTC/status/2021228504453386667) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-10T14:23Z [----] followers, [----] engagements


"My watch list near term catalysts $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET + NDA DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $NKTR 52w AD maintenance $BLTE NDA STGD1 H1 Add to stocks with near term catalysts $ABEO Q4 ER mid Feb. Expect a nice surprise & bullish outlook $VRDN TED SQ ph3 data. If positive expect a nice bump up bc SQ will capture the full market vs $AMGN $CMPS ph3 TRD 26w data init a rolling NDA Add to stocks with near term catalysts $ABEO Q4 ER mid Feb. Expect a nice"  
[X Link](https://x.com/Andre_AGTC/status/2020577692987605492) [@Andre_AGTC](/creator/x/Andre_AGTC) 2026-02-08T19:17Z [----] followers, 17.4K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Mineralys Therapeutics, Inc. (MLYS)

MLYS stock shows mixed signals with a director's significant share purchase boosting confidence, yet social mentions and creator activity are sharply declining.

About Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for cardiovascular and renal diseases.
Mineralys Therapeutics, Inc. uses the ticker $MLYS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Mineralys Therapeutics, Inc. (MLYS) market dominance near a 52-week low at [-------].
  • Mineralys Therapeutics, Inc. (MLYS) trading volume is up 14.78% from the previous week.
  • Mineralys Therapeutics, Inc. (MLYS) social dominance is up 878.95% from the previous week.
  • Mineralys Therapeutics, Inc. (MLYS) creators is up 64.05% from the previous month.
  • Mineralys Therapeutics, Inc. (MLYS) engagements is up 65.76% from the previous week.
  • Mineralys Therapeutics, Inc. (MLYS) mentions is up 87.4% from the previous month.
  • Mineralys Therapeutics, Inc. (MLYS) posts created is up 177.78% from the previous week.

Price: $27.60

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is experiencing volatility near its 52-week high, potentially due to decreased social mentions and creator activity, suggesting a short-term correction despite positive trial results and analyst upgrades.

24-Hour: 0.5% 7-Day: -9.74% 30-Day: -15.7%

1-Year High: $47.30 on 2025-11-12
1-Year Low: $8.80 on 2025-02-25

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Mineralys Therapeutics, Inc. (MLYS) is currently AltRank #1,368 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +1,289
[--] Month: [-----] +309
[--] Months: [-----] +901
[--] Year: [-----] +1,029
1-Year High: [-----] on 2025-11-06
1-Year Low: [--] on 2025-09-21

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-03-10
1-Year Low: [--] on 2025-04-25

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +66%
[--] Month: [-------] +5.60%
[--] Months: [---------] +52%
[--] Year: [---------] +158%
1-Year High: [-------] on 2025-09-02
1-Year Low: [---] on 2025-08-09

Engagements by network (24h): Reddit: [--] X: [-----] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +22%
[--] Month: [---] +87%
[--] Months: [-----] +58%
[--] Year: [-----] +782%
1-Year High: [---] on 2025-09-03
1-Year Low: [--] on 2025-08-09

Mentions by network (24h): Reddit: [--] X: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Mineralys Therapeutics, Inc. (MLYS) in the last [--] hours which is down 15% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +14%
[--] Month: [---] +64%
[--] Months: [---] -9%
[--] Year: [-----] +680%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-08-18

The most influential creators that mention Mineralys Therapeutics, Inc. in the last [--] hours

Creator Rank Followers Posts Engagements
@doepke_michel [--] [------] [--] [-----]
@Andre_AGTC [--] [-----] [--] [-----]
@Angelinafrazier [--] [--] [--]
@Lisa60841638541 [--] [--] [--] [--]
@InsideDashboard [--] [-----] [--] [--]

View More

Sentiment: 88%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 88%
Daily Average: 77%
[--] Week: 100% no change
[--] Month: 77% +3%
[--] Months: 77% -3%
[--] Year: 77% +10%
1-Year High: 100% on 2025-02-16
1-Year Low: 15% on 2025-12-29

Most Supportive Themes:

  • Director Share Purchase: (40%) Director Srinivas Akkaraju purchased $15M in shares, signaling confidence.

Most Critical Themes:

  • Declining Social Activity: (30%) Mentions of MLYS are down 77% and creators mentioning MLYS are down 84% over the last month.

Social Dominance: 0.00327%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00327%
Daily Average: 0.00903%
[--] Week: 0.037% +0.033%
[--] Month: 0.005% +0.0012%
[--] Months: 0.005% +0.0027%
[--] Year: 0.005% -0.003%
1-Year High: 0.061% on 2025-09-03
1-Year Low: 0.0013% on 2025-08-09

Market Dominance: 0.00251%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00251%
Daily Average: 0%
1-Year High: 0.00448% on 2025-11-12
1-Year Low: 0.00247% on 2026-02-13

Market Cap: $2,215,918,768

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,215,918,768
Daily Average: $2,952,989,812
[--] Week: $2,215,918,768 -8.40%
[--] Month: $2,215,918,768 -11%
1-Year High: $3,745,694,117 on 2025-11-12
1-Year Low: $2,184,262,786 on 2026-02-13

Top Mineralys Therapeutics, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"My watch list of catalysts- update 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD $PVLA Ph3 mLM My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC"
X Link @Andre_AGTC 2026-02-12T22:35Z [----] followers, [----] engagements

"My watch list of catalysts 👍$NKTR 36w AD 👍$BBIO Ph3 ACH $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA $CMPS Ph3 TRD $HELP Ph2 GAD My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3"
X Link @Andre_AGTC 2026-02-12T14:13Z [----] followers, [----] engagements

"My watch list near term catalysts 👍$NKTR 36w AD $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $BLTE NDA STGD1 H1 My watch list near term catalysts $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET + NDA DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $NKTR 52w AD maintenance $BLTE NDA STGD1 H1 My watch list near term catalysts $AXSM PDUFA ADA $XENE Ph3"
X Link @Andre_AGTC 2026-02-10T14:23Z [----] followers, [----] engagements

"My watch list near term catalysts $AXSM PDUFA ADA $XENE Ph3 FOS $PRAX NDA ET + NDA DEE $RVMD Ph3 PDAC L2 $ALMS Ph2b SLE $BBIO Ph3 ACH $TVTX PDUFA FSGS $VRDN Ph3 TED $MLTX Ph2 ax SpA $MLYS Ph2 OSA + NDA HTN $CMPS Ph3 TRD $HELP Ph2 GAD $NKTR 52w AD maintenance $BLTE NDA STGD1 H1 Add to stocks with near term catalysts $ABEO Q4 ER mid Feb. Expect a nice surprise & bullish outlook $VRDN TED SQ ph3 data. If positive expect a nice bump up bc SQ will capture the full market vs $AMGN $CMPS ph3 TRD 26w data init a rolling NDA Add to stocks with near term catalysts $ABEO Q4 ER mid Feb. Expect a nice"
X Link @Andre_AGTC 2026-02-08T19:17Z [----] followers, 17.4K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Mineralys Therapeutics, Inc. (MLYS)
/topic/$mlys